Achieve Life Sciences, Inc. (FRA:SP4P)
Germany · Delayed Price · Currency is EUR 4.090
0.00 (0.00%)
At close: Nov 28, 2025
Achieve Life Sciences Statistics
Total Valuation
FRA:SP4P has a market cap or net worth of EUR 212.93 million. The enterprise value is 180.11 million.
| Market Cap | 212.93M |
| Enterprise Value | 180.11M |
Important Dates
The next estimated earnings date is Friday, March 13, 2026.
| Earnings Date | Mar 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 53.23M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +34.94% |
| Shares Change (QoQ) | +47.09% |
| Owned by Insiders (%) | 4.84% |
| Owned by Institutions (%) | 42.52% |
| Float | 47.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 7.43 |
| P/TBV Ratio | 7.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.04 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.14, with a Debt / Equity ratio of 0.30.
| Current Ratio | 5.14 |
| Quick Ratio | 4.94 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -68.42 |
Financial Efficiency
Return on equity (ROE) is -161.08% and return on invested capital (ROIC) is -77.15%.
| Return on Equity (ROE) | -161.08% |
| Return on Assets (ROA) | -65.45% |
| Return on Invested Capital (ROIC) | -77.15% |
| Return on Capital Employed (ROCE) | -123.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.78M |
| Employee Count | 25 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.80% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -1.80% |
| 50-Day Moving Average | 3.51 |
| 200-Day Moving Average | 2.71 |
| Relative Strength Index (RSI) | 60.36 |
| Average Volume (20 Days) | 396 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.72 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -44.61M |
| Pretax Income | -44.61M |
| Net Income | -44.61M |
| EBITDA | -44.41M |
| EBIT | -44.61M |
| Earnings Per Share (EPS) | -1.15 |
Balance Sheet
The company has 41.01 million in cash and 8.49 million in debt, giving a net cash position of 32.52 million.
| Cash & Cash Equivalents | 41.01M |
| Total Debt | 8.49M |
| Net Cash | 32.52M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 28.65M |
| Book Value Per Share | 0.54 |
| Working Capital | 34.37M |
Cash Flow
| Operating Cash Flow | -34.67M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:SP4P does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.94% |
| Shareholder Yield | -34.94% |
| Earnings Yield | -20.95% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 31, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jul 31, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |